VaramirStart free · no cardSign in
IOVA as of Oct 31 · 16:03 ET
IOVANasdaqBiological Products, (No Diagnostic Substances)

Iovance Biotherapeutics, Inc. · Brief

Next report

5 days

Nov 5 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
5 of 8≥ implied
avg implied
±18.9%
avg realized
±26.6%
Nov 7 '24±12.3%▼−13.80%×1.12
Feb 27 '25±23.2%▼−19.49%×0.84
May 8 '25±12.3%▼−44.79%×3.63
Aug 7 '25±23.0%▼−20.08%×0.87
Nov 6 '25±27.6%▲+27.62%×1.00
Q1 FY26±19.1%▲+30.80%×1.62
May 7 '26±16.0%▼−13.20%×0.83
Q2 FY26±17.9%▲+43.09%×2.40
quarterimplied−45%0+45%realized×
Q2 FY26±17.9%▲+43.09%×2.40
May '26±16.0%▼−13.20%×0.83
Q1 FY26±19.1%▲+30.80%×1.62
Nov '25±27.6%▲+27.62%×1.00
Aug '25±23.0%▼−20.08%×0.87
May '25±12.3%▼−44.79%×3.63
2 older reports
Feb '25±23.2%▼−19.49%×0.84
Nov '24±12.3%▼−13.80%×1.12
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 3

+19.21%ten largest reporting managers increasing aggregate shares held over the latest quarter13F · Jun 30 '26
13disclosed supplier and customer ties in SEC filingsSEC filings

Bear2 of 3

8 of 24largest reporting managers reducing their stake in the latest quarter13F · Jun 30 '26
3 of 8recent reports where the move came in under the options implied rangeEarnings history
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

IOVA report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±23.5% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.